P3 Health Partners reported a second-quarter profit and raised its full-year 2026 adjusted EBITDA guidance. Revenue rose 9% to $386.4 million, and the company posted net income of $15.7 million, reversing a $43.7 million loss a year earlier. Adjusted EBITDA reached $54.4 million, compared with a loss of $17.1 million in the prior-year quarter. The company now expects full-year adjusted EBITDA between $80 million and $110 million, up from a previous outlook that implied a significant improvement over the $161.3 million loss in fiscal 2025. Total revenue is projected at $1.5 billion to $1.6 billion, with medical margin forecast at $260 million to $300 million.
P3 Health Partners IncP3 Health Partners swung to a Q2 profit and raised its full-year 2026 adjusted EBITDA guidance, indicating improved financial performance.
